Beth A Rousseau, Ph.D.
Postdoctoral Associate
Department:
MD-PEDS-INFECTIOUS DISEASES
Business Phone:
(352) 273-8010
Business Email:
brousseau@ufl.edu
About Beth A Rousseau
I study lytic reactivation in Burkitt lymphoma and lymphoblastoid cell lines. My projects often involve the use of small molecules that alter the state of chromatin in the cell. Epigenetic factors are important in reactivation of EBV from the latent state. My research will be informative for designing oncolytic therapies for EBV related lymphomas.
Publications
Academic Articles
2025
Leveraging the interconnected unfolded protein response and NLRP3 inflammasome pathways to reactivate Epstein-Barr virus in diffuse large B-cell lymphomas.
NAR cancer.
7(2)
[DOI] 10.1093/narcan/zcaf017.
[PMID] 40330549.
2024
KAP1/TRIM28 – antiviral and proviral protagonist of herpesvirus biology.
Trends in microbiology.
32(12):1179-1189
[DOI] 10.1016/j.tim.2024.05.007.
[PMID] 38871562.
2023
Inflammation and Epstein-Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection.
Viruses.
15(4)
[DOI] 10.3390/v15040949.
[PMID] 37112929.
2022
IFI16 Partners with KAP1 to Maintain Epstein-Barr Virus Latency.
Journal of virology.
96(17)
[DOI] 10.1128/jvi.01028-22.
[PMID] 35969079.
2018
Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis.
Molecular cell.
69(5):906-914.e4
[DOI] 10.1016/j.molcel.2018.01.025.
[PMID] 29456189.
Contact Details
Phones:
- Business:
- (352) 273-8010
Emails:
- Business:
- brousseau@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100296
GAINESVILLE FL 32610 - Business Street:
-
R1-179
1200 Newell Dr ARB
GAINESVILLE FL 32610